{
  "Variants Include": [
    {
      "Gene": "PRNP",
      "variants": [
        {
          "HGVS": "NM_000007.4:c.178G>A",
          "cDNA Change": {
            "transcript": "NM_000007.4",
            "ref": "G",
            "alt": "A",
            "position": "178"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "59"
          },
          "Description in input context": "The G178A variant in PRNP was associated with altered prion processing."
        },
        {
          "HGVS": "NM_000007.4:c.219T>C",
          "cDNA Change": {
            "transcript": "NM_000007.4",
            "ref": "T",
            "alt": "C",
            "position": "219"
          },
          "Protein Change": {
            "ref": "T",
            "alt": "C",
            "position": "73"
          },
          "Description in input context": "The T219C variant in PRNP demonstrated a partial loss of normal prion folding."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Prion Disease (Sporadic Creutzfeldt-Jakob Disease)",
    "MONDO": "MONDO:0002001"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cellular prion resistance assay (CpRA)",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Neuro-2a cells",
        "Description": "The CpRA was performed using Neuro-2a cells."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000007.4:c.178G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "CpRA demonstrated a 5-log reduction in prion infectivity for cells expressing the G178A variant."
        },
        {
          "Variant": "NM_000007.4:c.219T>C",
          "Conclusion": "Intermediate",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "CpRA showed a 2-log reduction in prion infectivity for cells expressing the T219C variant compared to wild type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent experiments were conducted, each with three biological replicates."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each replicate was performed in triplicate wells."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PRNP cDNA was transfected as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection served as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA followed by Tukey's post-hoc test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Log reduction of prion infectivity > 7",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Log reduction of prion infectivity < 3",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}